Grove Bank & Trust Charles River Laboratories International, Inc. Transaction History

Grove Bank & Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$255.51 - $362.11 $173,746 - $246,234	-680 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$294.17 - $371.65 $200,035 - $252,721	680 New	680 $252,000
Q1 2018 May 07, 2018	SELL	$98.19 - $115.2 $66,769 - $78,336	-680 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $65,769 - $74,296	680	680 $73,000

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.81B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Grove Bank & Trust with notifications on news.